ROSUVASTATIN/EZETIMIBE TEVA 10MG/10 MG TBL NOB 30
What is the maximum co-payment for ROSUVASTATIN/EZETIMIBE TEVA?
If the insurance company contributes, the maximum co-payment is 550,17 Kč. The maximum pharmacy price is 932,97 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
Yes, but check the specialization of the prescribing physician below (a so-called non-delegable prescription).
Does ROSUVASTATIN/EZETIMIBE TEVA have a counted co-payment set?
Yes, the medicine has a counted co-payment of 40,00 Kč. Learn more about the protective limit here.
How much does the insurance company pay for one dispensed reimbursed pack?
382,80 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Rychlý přehled
| Dosage form | Tablets uncoated |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, zkontrolujte ale specializaci předepisujícího lékaře níže (tzv. nedelegovatelná preskripce). Maximální doplatek: 550,17 Kč. Maximální cena: 932,97 Kč. |
| Kdo může předepsat | cardiology, pediatric cardiology, angiologyinternal medicinediabetologyspecialized center for the treatment of hyperlipoproteinemia |
| Složení | More information about the composition can be found in the SPC, section 6.1. |
| Dostupnost / výpadek | Ukončeno The latest report from the manufacturer is from 31. 3. 2023. Výroba byla ukončena s platností od 8. 1. 2024. The manufacturer lists medicines with the following code as a potential substitute: 022523002252320225234022703802270390227277022728102406270240629 |
| Kód SÚKL | 0224293 |
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe ROSUVASTATIN/EZETIMIBE TEVA?
- cardiology, pediatric cardiology, angiology
- internal medicine
- diabetology
- specialized center for the treatment of hyperlipoproteinemia
What is the composition of ROSUVASTATIN/EZETIMIBE TEVA?
. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
- Documents could not be found v lokální importní databázi.
Which medicines are similar to ROSUVASTATIN/EZETIMIBE TEVA?
The medicine belongs to ATC group C10BA06. Název skupiny není v lokální importní databázi dostupný.
Who manufactures ROSUVASTATIN/EZETIMIBE TEVA?
Informace o výrobci není dostupná.
Is the medicine in shortage?
The latest report from the manufacturer is from 31. 3. 2023. Production was terminated with effect from 8. 1. 2024. The manufacturer lists medicines with the following code as a potential substitute:
What is the unique code for ROSUVASTATIN/EZETIMIBE TEVA?
The medicine has code 0224293. Code details can be found here.
How many packs of ROSUVASTATIN/EZETIMIBE TEVA were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of ROSUVASTATIN/EZETIMIBE TEVA were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 22. 06. 2026